Parshall B Lynne
Cytokinetics, Incorporated - Common Stock · Director
Parshall B Lynne is listed in filings as Director at Cytokinetics, Incorporated - Common Stock. This profile follows SEC Form 4 activity through Jun 1, 2026, including sale activity. Recent filings connect the profile to Cytokinetics, Incorporated - Common Stock (CYTK), Ionis Pharmaceuticals Inc (IONS), and Foghorn Therapeutics Inc. (FHTX). The current snapshot covers public activity from Jun 28, 2024 to Jun 1, 2026. Reported amounts are shown as $370.4K to $340.3K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $340k4.5k shares | SellApr 15, 2026 | $76.19 | $76.49 | |
| $41k534 shares | SellApr 15, 2026 | $76.97 | $76.49 | |
| $306k5k shares | SellMar 2, 2026 | $61.21 | $67.90 | |
| $414k5k shares | SellFeb 11, 2026 | $82.72 | $76.49 | |
| $324k5k shares | SellNov 19, 2025 | $64.73 | $67.90 |